Abstract
Spontaneous intracerebral hemorrhage (ICH) is by far the most destructive form of stroke1. Morbidity and mortality have not substantially changed over the last 30years and current treatment options lag behind those for ischemic stroke and subarachnoid hemorrhage1. Apart from the management in a specialized stroke or neurological intensive care unit, no specific therapies have been shown to consistently improve outcomes after ICH2. As the most common etiology of ICH is hypertension3.this places a large proportion of the population at risk.
Original language | English |
---|---|
Title of host publication | Handbook of Neuroemergency Clinical Trials |
Publisher | Elsevier |
Pages | 47-64 |
Number of pages | 18 |
ISBN (Electronic) | 9780128040645 |
ISBN (Print) | 9780128041017 |
DOIs | |
State | Published - 1 Jan 2017 |
Keywords
- ATACH
- Cerebral blood flow
- MISTIE
- Neuroprotection
- STICH
- Systolic blood pressure